Key drivers of biomedical innovation in cancer drug discovery
Abstract Discovery and translational research has led to the identification of a series of “cancer drivers”—genes that, when mutated or otherwise misregulated, can drive malignancy. An increasing number of drugs that directly target such drivers have demonstrated activity in clinical trials and are...
Saved in:
| Main Authors: | Margit A Huber, Norbert Kraut |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2014-11-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201404596 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antimalarial drug resistance and drug discovery: learning from the past to innovate the future
by: Liana Theodoridis, et al.
Published: (2025-08-01) -
Innovative Progress in Bacterial Cellulose for Biomedical Applications
by: Sharise Berton, et al.
Published: (2025-05-01) -
A Review of Recent Advancement in Integrating Omics Data with Literature Mining towards Biomedical Discoveries
by: Kalpana Raja, et al.
Published: (2017-01-01) -
From Nutrition to Innovation: Biomedical Applications of Egg Components
by: Amin Mohseni Ghalehghazi, et al.
Published: (2025-08-01) -
Design of preclinical studies of biomedical cell products: characteristics, key principles and requirements
by: E. V. Melnikova, et al.
Published: (2018-02-01)